Consolidated Statement Of Income

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7305469

Concept 2024-03-01 to
2024-08-31
2023-03-01 to
2023-08-31
Consolidated statement of income
Statement of income
Net sales
75,456,000,000 JPY
66,977,000,000 JPY
Ordinary expenses
Other operating expenses
Share of loss of entities accounted for using equity method
137,000,000 JPY
22,000,000 JPY
Cost of sales
31,047,000,000 JPY
28,330,000,000 JPY
Operating expenses
Selling, general and administrative expenses
35,402,000,000 JPY
30,250,000,000 JPY
Operating expenses
Net sales
Gross profit (loss)
44,408,000,000 JPY
38,646,000,000 JPY
Operating profit (loss)
9,006,000,000 JPY
8,396,000,000 JPY
Ordinary profit (loss)
10,788,000,000 JPY
11,640,000,000 JPY
Operating expenses
Research and development expenses
5,106,000,000 JPY
4,140,000,000 JPY
Extraordinary income
2,315,000,000 JPY
JPY
Gain on disposal of non-current assets
12,000,000 JPY
JPY
Non-operating income
Interest income
1,461,000,000 JPY
1,128,000,000 JPY
Dividend income
648,000,000 JPY
567,000,000 JPY
Other
446,000,000 JPY
335,000,000 JPY
Non-operating income
2,555,000,000 JPY
3,336,000,000 JPY
Cost of sales
Selling, general and administrative expenses
Advertising expenses
8,005,000,000 JPY
6,823,000,000 JPY
Non-operating expenses
Interest expenses
16,000,000 JPY
7,000,000 JPY
Other
36,000,000 JPY
15,000,000 JPY
Non-operating expenses
773,000,000 JPY
91,000,000 JPY
Extraordinary losses
2,000,000 JPY
2,000,000 JPY
Loss on disposal of non-current assets
2,000,000 JPY
2,000,000 JPY
Gross profit
Profit (loss) before income taxes
13,101,000,000 JPY
11,638,000,000 JPY
Extraordinary income
Gain on sale of investment securities
2,303,000,000 JPY
JPY
Extraordinary losses
Income taxes
3,700,000,000 JPY
2,967,000,000 JPY
Profit (loss)
9,401,000,000 JPY
8,671,000,000 JPY
Profit (loss) attributable to non-controlling interests
303,000,000 JPY
253,000,000 JPY
Profit (loss) attributable to owners of parent
9,098,000,000 JPY
8,417,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
200,000,000 JPY
4,422,000,000 JPY
Foreign currency translation adjustment
11,594,000,000 JPY
8,303,000,000 JPY
Remeasurements of defined benefit plans, net of tax
-156,000,000 JPY
-93,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
33,000,000 JPY
97,000,000 JPY
Other comprehensive income
11,672,000,000 JPY
12,729,000,000 JPY
Profit attributable to
Comprehensive income
21,073,000,000 JPY
21,400,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
20,731,000,000 JPY
21,036,000,000 JPY
Comprehensive income attributable to non-controlling interests
342,000,000 JPY
364,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.